| Not Yet Recruiting | A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonar Idiopathic Pulmonary Fibrosis | Phase 2 | 2026-06-01 |
| Recruiting | Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma Asthma | Phase 2 | 2025-12-17 |
| Recruiting | Evaluation of Safety, Side Effects and How the Drug CHF6467 Administered Via Intranasal Route is Absorbed, Mod Healthy Volunteers | Phase 1 | 2025-09-15 |
| Recruiting | A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Fabry Disease | Phase 2 / Phase 3 | 2025-07-29 |
| Recruiting | Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® Fabry Disease, Pregnancy, Pregnancy Complications | — | 2025-05-23 |
| Recruiting | A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Epidermolysis Bullosa, Junctional Epidermolysis Bullosa, Epidermolysis Bullosa, Dystrophic | Phase 3 | 2025-04-18 |
| Completed | A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and E Asthma | Phase 2 | 2025-03-28 |
| Completed | Effect of Cyclosporine Drug Interaction on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Vo Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | 2025-03-18 |
| Recruiting | Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age Alpha-Mannosidosis | — | 2025-02-19 |
| Completed | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Mult Pulmonary Fibrosis | Phase 1 | 2025-01-13 |
| Recruiting | A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients Fabry Disease | — | 2024-11-06 |
| Completed | Real-World Effectiveness of a Triple Combination BDP/FF/GB in a Single Pressurised Metered Dose Inhaler in COP Chronic Obstructive Pulmonary Disease | — | 2024-07-02 |
| Completed | Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers Chronic Obstructive Pulmonary Disease | Phase 1 | 2024-03-28 |
| Recruiting | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Bronchiectasis | Phase 1 / Phase 2 | 2023-11-29 |
| Completed | Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma | Phase 3 | 2023-11-27 |
| Terminated | Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy Uncontrolled Asthma | Phase 2 | 2023-11-26 |
| Recruiting | Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease Fabry Disease | Phase 2 / Phase 3 | 2023-08-01 |
| Completed | Study to Assess the Effect of the New HFA-152a Propellant on Mucociliary Clearance Mucociliary Clearance | Phase 1 | 2023-06-26 |
| Completed | Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropion Asthma | Phase 1 | 2023-04-24 |
| Completed | A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV) Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | 2023-03-29 |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients Idiopathic Pulmonary Fibrosis | Phase 1 | 2023-01-25 |
| Recruiting | PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI Chronic Obstructive Pulmonary Disease | — | 2022-12-02 |
| Completed | A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg To Asthma | Phase 3 | 2022-08-31 |
| Completed | A Study to Compare the Effects of Two Propellants in Adults With Mild Asthma Asthma | Phase 2 | 2022-08-03 |
| Completed | PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers Chronic Obstructive Pulmonary Disease | Phase 1 | 2022-07-29 |
| Completed | Clinical Study to Investigate the Pharmacokinetics, Safety and Tolerability Following Single Administration of Chronic Obstructive Pulmonary Disease | Phase 1 | 2022-05-05 |
| Completed | A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fix COPD, COPD Exacerbation | Phase 3 | 2022-04-28 |
| Withdrawn | Efficacy and Safety of CUSA-081 in the Restoration of Dysfunctional Central Venous Access Device (CVAD) Functi Restoration of Function to CVADs | Phase 3 | 2022-02-28 |
| Terminated | Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Asthma | Phase 4 | 2022-02-25 |
| Completed | Study in Adult Patients With Moderate to Severe Asthma Asthma | Phase 3 | 2022-02-24 |
| Completed | Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion Fabry Disease | — | 2022-01-26 |
| Completed | CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD Chronic Obstructive Pulmonary Disease | Phase 4 | 2021-10-28 |
| Withdrawn | TRIMBOW® and RELVAR® on Lung Stiffness Reduction Assessed Through Forced Oscillation Technique in Patients Wit COPD | Phase 4 | 2021-10-04 |
| Terminated | A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast) Chronic Obstructive Pulmonary Disease | Phase 3 | 2021-07-14 |
| Terminated | A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and S Chronic Obstructive Pulmonary Disease | Phase 3 | 2021-07-12 |
| Completed | Functional Respiratory Imaging Study (DARWiIN) Chronic Obstructive Pulmonary Disease | Phase 3 | 2021-05-18 |
| Terminated | A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Throug Respiratory Distress Syndrome (RDS) | Phase 3 | 2021-05-18 |
| Completed | Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects Chronic Obstructive Pulmonary Disease (COPD), COPD | Phase 1 | 2021-03-10 |
| Completed | Study on Patterns of Care in Mild Asthmatic Patients Asthma | — | 2021-02-25 |
| Completed | Investigation of the Effect of Inhibition of CYP3A4/5 by Itraconazole on the PK of CHF6001 (Tanimilast) Chronic Obstructive Pulmonary Disease | Phase 1 | 2021-02-22 |
| Withdrawn | Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis Alpha-Mannosidosis | Phase 3 | 2021-01-11 |
| Terminated | Poractant Alfa (Curosurf®)) -- Effect in Adult Patients Diagnosed With 2019 Novel Coronavirus (SARS-COV-19; (C Acute Respiratory Distress Syndrome | Phase 2 | 2021-01-06 |
| Terminated | CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome Neonatal Opioid Withdrawal Syndrome | Phase 2 | 2020-12-18 |
| Completed | ARCANGELO (itAlian pRospective Study on CANGrELOr) Acute Coronary Syndrome | — | 2020-10-23 |
| Terminated | Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality Catheter Occlusion, Thrombosis | Phase 3 | 2020-02-12 |
| Completed | Registry Study of Revcovi Treatment in Patients With ADA-SCID Adenosine Deaminase Severe Combined Immunodeficiency | — | 2019-09-30 |
| Terminated | Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma Asthma; Eosinophilic | Phase 3 | 2019-08-28 |
| Completed | Effect of the Use of an add-on Device Connected to a Smartphone App on Difficult-to-treat Asthmatic Patient's Asthma | N/A | 2019-08-12 |
| Completed | Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects COPD | Phase 1 | 2019-07-24 |
| Completed | A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Cystic Fibrosis, Non-Cystic Fibrosis Bronchiectasis | Phase 1 | 2019-05-27 |
| Completed | PK Linearity and Steady State PK of CHF 6532 in Healthy Subjects Asthma | Phase 1 | 2019-05-10 |
| Completed | PK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. Caucasians Asthma, Chronic Obstructive Pulmonary Disease | Phase 1 | 2019-03-18 |
| Terminated | Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients Chronic Obstructive Pulmonary Disease, Asthma | Phase 1 | 2019-01-14 |
| Active Not Recruiting | Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients Fabry Disease | Phase 3 | 2018-11-13 |
| Completed | CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer Diabetic Neuropathic Foot Ulcers | Phase 1 / Phase 2 | 2018-10-17 |
| Completed | Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease Fabry Disease | Phase 3 | 2018-09-16 |
| Completed | The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipi Kidney Transplant | — | 2018-07-31 |
| Completed | Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient Chronic Obstructive Pulmonary Disease | Phase 3 | 2018-07-30 |
| Completed | Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Chronic Obstructive Pulmonary Disease | Phase 2 | 2018-06-15 |
| Completed | A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy V Asthma, Chronic Obstructive Pulmonary Disease | Phase 1 / Phase 2 | 2017-12-28 |
| Completed | Functional Respiratory Imaging Study (FRI) Chronic Obstructive Pulmonary Disease | Phase 3 | 2017-11-20 |
| Completed | Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Contr Asthma | Phase 3 | 2017-10-09 |
| Completed | A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Asthma | Phase 2 | 2017-09-08 |
| Terminated | A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Re Neonatal Respiratory Distress Syndrome | Phase 2 | 2017-08-28 |
| Completed | An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects Asthma | Phase 2 | 2017-07-28 |
| Completed | A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease COPD, Chronic Obstructive Pulmonary Disease | Phase 2 | 2017-07-28 |
| Completed | A Study to Evaluate the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 NEXThaler i Asthma | Phase 2 | 2017-02-28 |
| Completed | Cangrelor Neonatal PK/PD and Safety Study Partial Obstruction of Systemic to Pulmonary Artery Shunt, Complete Obstruction of Systemic to Pulmonary Artery Shunt | Phase 1 | 2017-01-03 |
| Completed | Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Stu Kidney Transplantation | Phase 2 | 2017-01-01 |
| Completed | A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients Chronic Obstructive Pulmonary Disease | Phase 2 | 2016-12-15 |
| Completed | Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patien COPD (Chronic Obstructive Pulmonary Disease) | Phase 3 | 2016-12-14 |
| Completed | Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis Alpha-Mannosidosis | Phase 2 | 2016-12-01 |
| Completed | Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI Chronic Obstructive Pulmonary Disease, Asthma | Phase 1 | 2016-11-21 |
| Completed | A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Heal Non-Cystic Fibrosis Bronchiectasis, Cystic Fibrosis | Phase 1 | 2016-11-01 |
| Completed | Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe CO COPD | Phase 2 | 2016-10-31 |
| Completed | Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma Severe Eosinophilic Asthma | Phase 2 | 2016-09-01 |
| Completed | Clinical Pharmacology of 35/4 NEXThaler® in Children 5-11 Years Old Asthma | Phase 2 | 2016-08-01 |
| Completed | TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER) Asthma | Phase 3 | 2016-04-06 |
| Completed | Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in H COPD | Phase 1 | 2016-04-01 |
| Completed | Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2016-02-29 |
| Completed | TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA Asthma | Phase 3 | 2016-02-17 |
| Terminated | A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses Chronic Obstructive Pulmonary Disease | Phase 1 / Phase 2 | 2016-01-22 |
| Completed | A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Respiratory Distress Syndrome, Newborn | Phase 2 | 2016-01-21 |
| Completed | Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001 Copd | Phase 1 | 2016-01-01 |
| Completed | Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients Organ or Tissue Transplant; Complications | Phase 4 | 2015-07-01 |
| Completed | 2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2015-05-29 |
| Completed | Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® End Stage Renal Disease | Phase 4 | 2015-05-01 |
| Completed | Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopy Chronic Obstructive Pulmonary Disease | Phase 3 | 2015-05-01 |
| Completed | Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Asthma | Phase 1 | 2015-02-01 |
| Completed | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001 Chronic Obstructive Pulmonary Disease | Phase 1 | 2014-11-01 |
| Completed | Efficacy of LAMA Added to ICS in Treatment of Asthma Asthma | Phase 2 | 2014-11-01 |
| Completed | AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Asthma | — | 2014-06-30 |
| Completed | Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients Chronic Obstructive Pulmonary Disease | Phase 2 | 2014-06-01 |
| Completed | Drug-drug Interaction Study of CHF5993 With Cimetidine COPD | Phase 1 | 2014-05-01 |
| Completed | Triple in Asthma Dose Finding Asthma | Phase 2 | 2014-04-11 |
| Completed | A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler Asthma | Phase 2 | 2014-04-01 |
| Completed | Study to Investigate the Pharmacokinetics of CHF 6001 DPI Administered Via Nexthaler® Device or the Capsule fo COPD | Phase 1 | 2014-04-01 |
| Terminated | Assessment of Efficacy, Safety and Dosing of Clevidipine in Pediatric Participants Undergoing Surgery (PIONEER Pediatric Perioperative Blood Pressure Management | Phase 4 | 2014-03-17 |
| Completed | Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients COPD | Phase 1 | 2014-03-01 |
| Completed | Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD Chronic Obstructive Pulmonary Disease | Phase 3 | 2014-03-01 |
| Withdrawn | Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Asse Asthma in Children | Phase 3 | 2014-02-01 |
| Completed | A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal I Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | 2014-01-01 |
| Completed | Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Chronic Obstructive Pulmonary Disease | Phase 3 | 2014-01-01 |
| Completed | An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients COPD | Phase 2 | 2013-12-01 |
| Completed | A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD COPD | Phase 2 | 2013-12-01 |
| Completed | Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients Alpha-Mannosidosis | Phase 3 | 2013-08-01 |
| Completed | Lamazym Aftercare Study Alpha-Mannosidosis | Phase 3 | 2013-06-01 |
| Completed | beCLomethasone Efficacy in Acute Rhinosinusitis - CLEAR Study Acute Rhinosinusitis | Phase 3 | 2013-01-01 |
| Completed | Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two S Asthmatic | Phase 2 | 2012-11-01 |
| Completed | Safety, Tolerability and Efficacy of 28-day Inhaled CHF 6001 DPI in COPD Patients COPD | Phase 2 | 2012-10-01 |
| Completed | First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome Respiratory Distress Syndrome in Premature Infants | Phase 1 | 2012-10-01 |
| Completed | A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in A Asthma | Phase 2 | 2012-10-01 |
| Completed | Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000 Cystic Fibrosis | — | 2012-09-01 |
| Completed | A Study in Patients With Asthma Asthma | Phase 3 | 2012-07-01 |
| Completed | An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Po Asthma | Phase 2 | 2012-06-01 |
| Completed | International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison) Asthma | — | 2012-05-01 |
| Completed | Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potent Alzheimer's Disease | Phase 2 | 2012-05-01 |
| Completed | Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients Asthma | Phase 3 | 2012-04-20 |
| Completed | Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1 Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2012-04-01 |
| Completed | Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate Pulmonary Disease, Chronic Obstructive | Phase 2 | 2012-03-01 |
| Completed | Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients Asthma | Phase 2 | 2012-02-01 |
| Completed | Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmat Asthma | Phase 2 | 2011-12-01 |
| Completed | Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old Asthma in Children | Phase 2 | 2011-11-01 |
| Completed | Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml Postmenopausal Osteoporosis | Phase 3 | 2011-10-01 |
| Completed | Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Asse Childhood Asthma | Phase 3 | 2011-09-01 |
| Terminated | A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR) Chronic Obstructive Pulmonary Disease | Phase 3 | 2011-09-01 |
| Completed | Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children Asthma | Phase 3 | 2011-09-01 |
| Completed | Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potent Alzheimer's Disease | Phase 2 | 2011-07-01 |
| Completed | Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV) Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | 2011-07-01 |
| Completed | Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI Asthma | Phase 2 | 2011-05-01 |
| Completed | Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers COPD | Phase 1 | 2011-05-01 |
| Completed | Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Pulmonary Disease, Chronic Obstructive | Phase 4 | 2011-04-01 |
| Completed | A Study in Patients With Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease | Phase 3 | 2011-04-01 |
| Completed | Pilot Pharmacokinetic Clenil Study With AeroChamber Plus™ or Volumatic™ Spacer Devices Asthma | Phase 2 | 2011-04-01 |
| Completed | Efficacy of CHF1535 Via NEXT DPI Versus pMDI and BDP DPI100µg on PeakExpiratoryFlow in Asthmatic Patients Asthma | Phase 3 | 2011-03-01 |
| Completed | Prevalence and Reversibility of Lung Hyperinflation in Asthma Asthma | — | 2011-02-01 |
| Completed | A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclometha Asthma | Phase 2 | 2010-10-01 |
| Completed | Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 / Phase 2 | 2010-08-01 |
| Completed | Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Pulmonary Disease, Chronic Obstructive, Asthma | Phase 1 / Phase 2 | 2010-08-01 |
| Completed | Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer Cystic Fibrosis | Phase 1 | 2010-07-01 |
| Completed | Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers Healthy | Phase 1 | 2010-07-01 |
| Terminated | Efficacy of Nebulized Beclomethasone Dipropionate (BDP) in the Treatment of Moderate Croup Croup | Phase 3 | 2010-04-01 |
| Completed | Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS) Respiratory Distress Syndrome, Newborn | — | 2010-03-01 |
| Completed | Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Asthma | Phase 2 | 2010-01-01 |
| Completed | BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate) Pulmonary Disease, Chronic Obstructive | Phase 3 | 2009-10-01 |
| Completed | Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Yea Asthma | Phase 2 | 2009-09-01 |
| Completed | A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrine Cystic Fibrosis | Phase 3 | 2009-09-01 |
| Completed | FACTO Study (Foster® As Complete Treatment Option) Asthmatic Patients | Phase 4 | 2009-05-01 |
| Completed | A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® Cystic Fibrosis | Phase 3 | 2009-04-01 |
| Completed | Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in As Asthma | Phase 3 | 2009-03-01 |
| Completed | A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT I Asthma | Phase 3 | 2009-02-01 |
| Completed | Next DPI LABA, Multicentre, 5-way Cross-over, Adult Asthmatic Patients Asthma | Phase 2 | 2009-02-01 |
| Completed | Prospective Study on Asthma Control Asthma | — | 2009-01-01 |
| Completed | Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Chronic Obstructive Pulmonary Disease | Phase 2 | 2008-12-01 |
| Completed | Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers Chronic Obstructive Pulmonary Disease | Phase 1 | 2008-10-01 |
| Completed | Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD Chronic Obstructive Pulmonary Disease | Phase 2 | 2008-04-01 |
| Completed | Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose In Mild Persistent Asthma | Phase 2 | 2008-02-01 |
| Completed | Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Pl Bronchial Asthma | Phase 3 | 2007-11-01 |
| Completed | Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propio Asthma | Phase 3 | 2007-04-01 |
| Completed | Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study Respiratory Distress Syndrome, Newborn | Phase 4 | 2007-03-01 |
| Completed | Foster With or Without Charcoal Block or Aerochamber Plus Healthy Volunteers | Phase 1 | 2006-12-01 |
| Completed | Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD Chronic Obstructive Pulmonary Disease | Phase 3 | 2006-12-01 |
| Completed | Dose Finding Study of CHF 4226 for Treating Patients With COPD Chronic Obstructive Pulmonary Disease | Phase 2 | 2006-10-01 |
| Completed | Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol Bronchial Asthma | Phase 3 | 2006-03-01 |
| Completed | Formoterol-HFA 3-month Study in Chronic Obstructive Pulmonary Disease (COPD) Patients Chronic Obstructive Pulmonary Disease | Phase 3 | 2005-08-01 |
| Completed | EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTIC Bronchial Asthma | Phase 3 | 2004-11-01 |
| Completed | Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budeso Bronchial Asthma | Phase 3 | 2004-09-01 |
| Completed | Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease ( Chronic Obstructive Pulmonary Disease | Phase 2 | 2004-09-01 |
| Completed | Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Mo Asthma | Phase 3 | 2004-08-01 |
| Completed | Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persi Asthma | Phase 3 | 2004-02-01 |
| Completed | As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma Asthma | Phase 3 | 2002-08-01 |
| Available | Expanded Access to Velmanase Alfa Alpha-Mannosidosis | — | — |
| Approved For Marketing | Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease Patients Fabry Disease | — | — |